READ MOREArticles1st May 2015NephroGenex Announces Proposed Offering of Common StockNephroGenex, Inc., a pharmaceutical company focused on the development of therapeutics to treat kidney disease, today announced that it has commenced an underwritten public offering of shares of its common stock and expects to raise gross proceeds of up to $30 million. In addition, NephroGenex expects to grant the underwriters a 30-day option to purchase up to an additional $4.5 million of shares of its common stock in connection with the offering. All of the shares in the offering will be sold by NephroGenex.
READ MOREArticles7th February 2014Pay-Day Loans Masking UK’s Credit CrisisThe growth of the pay-day loan and ‘debt management’ industries could be masking the full extent of the personal debt crisis in the UK, warns top 25 accountancy firm, Wilkins Kennedy LLP.
READ MOREArticles24th August 2020Why Gold Prices Have Been Hitting Record HighsGold prices continue to rally this month as the coronavirus pandemic of 2020 continues. The precious metal closed at a little above $2,000 (£1523.05) on August 5th - a record high in the history of gold. Its earlier record peak was in 2011, a few years into the global financial crisis, when investors pushed the price of gold past the $1,900 (£1446.90) threshold.
READ MOREArticles22nd September 2023How to hedge against the FX exposure? Top strategies revealedHow To Hedge Against The FX Exposure? Top Strategies Revealed In today’s globally connected marketplace, businesses face a myriad of opportunities and challenges. Among these, managing foreign exchange (FX) exposure is a critical concern. As companies expand their reach across borders, they inevitably find themselves at the mercy of currency fluctuations, which can have a […]